Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Does anyone trust this company?

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Apr 07, 2022 10:05am

64 Views

Post# 34583910

RE:Does anyone trust this company?

Why do you always focus on the negative but have nothng to say on anything positive?

I don't recall a single positive post from you on any good NR. You seem to be a "glass is half empty" kinda guy.

We get a couple of minor annoucements and you focus on no volume or SP didn't go up. But if there was bad NR and it went down you would be gloating about it. So on the realistic optimistism side, yea we had couple of NR that were not going to cause a big breakout, but they didn't cause the SP to drop to any degree either.

This is not to say a person should only look at the positive either. But you need a balance between realistic optimicism and unrealistic pessimissm.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)